Publications by authors named "I Santamaria"

The Mancha3D code is a versatile tool for numerical simulations of magnetohydrodynamic (MHD) processes in solar/stellar atmospheres. The code includes nonideal physics derived from plasma partial ionization, a realistic equation of state and radiative transfer, which allows performing high-quality realistic simulations of magnetoconvection, as well as idealized simulations of particular processes, such as wave propagation, instabilities or energetic events. The paper summarizes the equations and methods used in the Mancha3D (Multifluid (-purpose -physics -dimensional) Advanced Non-ideal MHD Code for High resolution simulations in Astrophysics 3D) code.

View Article and Find Full Text PDF

Background: Tauopathies are a subset of neurodegenerative diseases characterized by abnormal tau inclusions. Recently, we have discovered a new, human specific, tau isoform termed W-tau that originates by intron 12 retention. Our preliminary data suggests this newly discovered W-tau isoform might prevent aberrant aggregation of other tau isoforms but is significantly downregulated in tauopathies such as Alzheimer's disease.

View Article and Find Full Text PDF

Intracellular accumulation of hyperphosphorylated misfolded tau proteins are found in many neurodegenerative tauopathies, including Alzheimer's disease (AD). Tau pathology can impact cerebrovascular physiology and function through multiple mechanisms. In vitro and in vivo studies have shown that alterations in the blood-brain barrier (BBB) integrity and function can result in synaptic abnormalities and neuronal damage.

View Article and Find Full Text PDF
Article Synopsis
  • Neurogenesis, which helps the brain stay resilient, decreases in Alzheimer's disease (AD), leading to reactive astrocytes that hinder neurogenesis; restoring neurogenesis could potentially counteract neurodegenerative effects.
  • Researchers used a mouse model to explore the role of Nerve growth factor receptor (Ngfr) in promoting neurogenesis in astrocytes during AD, finding that Ngfr reduces a marker (Lcn2) associated with reactive astrocytes, thereby enhancing neurogenic outcomes.
  • The study indicates that by boosting Ngfr expression, it's possible to decrease amyloid plaques and improve neurogenesis, suggesting that targeting astrocytes to promote their neurogenic potential could offer new therapeutic strategies for Alzheimer's disease.
View Article and Find Full Text PDF